Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic Impairment
Clinical trial NCT03114540 · COMPLETED
Trial details
- NCT number
- NCT03114540
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-17
- Primary completion
- 2018-02-28
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.